RxSight (RXST) Other Non-Current Liabilities (2020 - 2024)

RxSight's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $1.7 million for Q4 2024.

• Quarterly Other Non-Current Liabilities rose 2197.3% year-over-year to $1.7 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1.7 million (up 2197.3% YoY) and the FY2024 annual result came in at $1.7 million, up 2197.3% from the prior year.
• Other Non-Current Liabilities was $1.7 million for Q4 2024 at RxSight, up from $74000.0 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $8.8 million in Q4 2020 and bottomed at $74000.0 in Q4 2023.
• A 4-year average of $2.2 million and a median of $888000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
• Peak annual rise in Other Non-Current Liabilities reached 2197.3% in 2024, while the deepest fall reached 2197.3% in 2024.
• RxSight's Other Non-Current Liabilities stood at $8.8 million in 2020, then sank by 70.45% to $2.6 million in 2021, then tumbled by 97.17% to $74000.0 in 2023, then surged by 2197.3% to $1.7 million in 2024.
• Business Quant data shows RXST's Other Non-Current Liabilities at $1.7 million in Q4 2024, $74000.0 in Q4 2023, and $75000.0 in Q3 2023.